- Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
Shilong Zhang et al, 2023, Oncology Reports CrossRef - USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation
Deng Yong Zhang et al, 2023, Cell Death & Disease CrossRef - Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer
Nar Bahadur Katuwal et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef - ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis
Mabel Perez-Oquendo et al, 2023, Molecular Cancer Research CrossRef - The role of USP51 in attenuating chemosensitivity of lung cancer cells to cisplatin by regulating DNA damage response
Feng Zhou et al, 2023, Biotechnology and Applied Biochemistry CrossRef - Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
Hae-Seul Choi et al, 2022, Cellular and Molecular Life Sciences CrossRef - Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming et al, 2023, Journal of Hematology & Oncology CrossRef - The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
Zhen Ye et al, 2023, Frontiers in Endocrinology CrossRef - Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
Jianjun Li et al, 2022, Discover Oncology CrossRef - Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and Metastasis
Mabel Perez-Oquendo et al, 2022, Cancers CrossRef - ZEB1: Catalyst of immune escape during tumor metastasis
Jiahui Lu et al, 2022, Biomedicine & Pharmacotherapy CrossRef